ABSTRACT
Cyclin-dependent kinases (Cdk) and their associated pathways represent some of the most attractive targets for the development of anticancer therapeutics. Based on antitumor activity in animal models, a variety of Cdk inhibitors are undergoing clinical evaluation either as a single agent or in combination with other approved drugs. In our anticancer drug discovery program, a novel series of flavones have been synthesized for evaluation against the activity of Cdk4-D1. This enzyme catalyzes the phosphorylation of retinoblastoma protein, thus inhibiting its function. We have identified a series of potent Cdk4-D1 inhibitors with IC(50) below 250 nmol/L. In this report, we have described the properties of one of the best compound, P276-00 of the flavone's series. P276-00 shows 40-fold selectivity toward Cdk4-D1, compared with Cdk2-E. The specificity toward 14 other related and unrelated kinases was also determined. P276-00 was found to be more selective with IC(50)s <100 nmol/L for Cdk4-D1, Cdk1-B, and Cdk9-T1, as compared with other Cdks, and less selective for non-Cdk kinases. It showed potent antiproliferative effects against various human cancer cell lines, with an IC(50) ranging from 300 to 800 nmol/L and was further compared for its antiproliferative activity against cancer and normal fibroblast cell lines. P276-00 was found to be highly selective for cancer cells as compared with normal fibroblast cells. To delineate its mechanism of action, the effect of P276-00 on cell cycle proteins was studied in human breast cancer cell line (MCF-7) and human non-small cell lung carcinoma (H-460). A significant down-regulation of cyclin D1 and Cdk4 and a decrease in Cdk4-specific pRb Ser(780) phosphorylation was observed. P276-00 produced potent inhibition of Cdk4-D1 activity that was found to be competitive with ATP and not with retinoblastoma protein. The compound also induced apoptosis in human promyelocytic leukemia (HL-60) cells, as evidenced by the induction of caspase-3 and DNA ladder studies. These data suggest that P276-00 has the potential to be developed as an anti-Cdk chemotherapeutic agent.
Subject(s)
Antineoplastic Agents/pharmacology , Breast Neoplasms/drug therapy , Carcinoma, Non-Small-Cell Lung/drug therapy , Cyclin-Dependent Kinases/antagonists & inhibitors , Enzyme Inhibitors/pharmacology , Flavones/pharmacology , Lung Neoplasms/drug therapy , Breast Neoplasms/enzymology , Carcinoma, Non-Small-Cell Lung/enzymology , Caspase 3/metabolism , Cell Cycle/drug effects , Cell Proliferation/drug effects , Cells, Cultured/drug effects , Cyclin D1/metabolism , Cyclin-Dependent Kinase 4/metabolism , Cyclin-Dependent Kinases/metabolism , Down-Regulation , Fibroblasts/cytology , Fibroblasts/drug effects , Fibroblasts/metabolism , Flavones/chemistry , HL-60 Cells/drug effects , Humans , In Vitro Techniques , Lung Neoplasms/enzymology , Molecular Structure , Phosphorylation/drug effects , Retinoblastoma Protein/metabolismABSTRACT
Laser-induced breakdown spectroscopy is an almost ideal technique for the in situ monitoring of the composition of a glass batch before it enters the glass-melting furnace, saving a significant amount of energy by the optimization of the furnace parameters for a particular composition of the glass batch. We investigate this application of laser-induced breakdown spectroscopy by determining the elemental composition of the glass batch used (i) as a surrogate for radioactive glass waste and (ii) to manufacture the most common type of flat glass. The surrogate glass-batch and flat-glass calibration curves for the major constituents have been prepared using both the line intensity and the line-intensity ratio. The analytical figure of merit of the glass-batch data obtained from the two different detection systems, namely, the Czerny-Turner spectrometer with an intensified diode-array detector and the echelle spectrometer fitted with an intensified CCD camera, are compared.
ABSTRACT
The synthesis and pharmacological evaluation of cis- and trans-6-amino-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ols 4a-c and 5a-c and cis- and trans-4-amino-2,3,4,5-tetrahydro-1-benzoxepin-5-ols 4d-f and 5d-f were carried out. Chemo- and stereoselective synthesis of 5a-f was achieved by reduction of corresponding alpha-amino ketones 3a-f with LiAl(t-BuO)3H. cis-4-Amino-2,3,4,5-tetrahydro-1-benzoxepin-5-ol 4d and trans-4-amino-2,3,4,5-tetrahydro-1-benzoxepin-5-ol 5d exhibited marked anorexigenic activity in mice at a dose of LD50 800 and 500 mg/kg and ED50 75 and 55 mg/kg, respectively, while the analog cis-2,3-dihydroxy-6-amino-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol 8 showed typical alpha-sympathomimetic activity.
Subject(s)
Appetite Depressants/chemical synthesis , Benzocycloheptenes/pharmacology , Benzoxepins/pharmacology , Sympathomimetics/chemical synthesis , Amphetamines/antagonists & inhibitors , Animals , Appetite Depressants/administration & dosage , Appetite Depressants/pharmacology , Benzocycloheptenes/administration & dosage , Benzocycloheptenes/chemical synthesis , Benzoxepins/administration & dosage , Benzoxepins/chemical synthesis , Blood Pressure/drug effects , Dose-Response Relationship, Drug , Drug Antagonism , Mice , Obesity/drug therapy , Stereoisomerism , Sympathomimetics/administration & dosage , Sympathomimetics/pharmacologyABSTRACT
The effect of various parameters on the accuracy of the laser-induced breakdown spectroscopy (LIBS) data taken from pellet samples has been investigated. The dependence of the standard deviation of the LIBS data on the amount and nature of the binder used, pressure used to press the powder into a pellet, and the position of the focal spot on the pellet has been investigated. Pellets made from industrially important materials such as silica, alumina, and lime with polyvinyl alcohol, sucrose, and starch as binders have been studied. The results thus obtained are tested by preparation of the calibration curves for Si, Fe, and B in the pellets made from the powder glass batch used as a surrogate for the batch employed for the vitrification of radioactive waste.
ABSTRACT
Semisynthetic modifications at Hydroxy tyrosine (Htyr) unit of mulundocandin (1) were carried out to improve its aqueous solubility. A single step introduction of substituted aminomethyl groups at the ortho position(s) of phenolic hydroxyl of HTyr unit of mulundocandin has been achieved in 7-85% yield. The in vitro screening of Mannich products against Candida albicans and Aspergillus fumigatus, retained the in vivo activity of parent by oral and intraperitoneal route. Compound 20, showed significant improvement in activity over mulundocandin (1) and activity compares well with that of fluconazole.
Subject(s)
Antifungal Agents/chemistry , Mannich Bases/chemical synthesis , Peptides, Cyclic/chemistry , Water/chemistry , Animals , Antifungal Agents/administration & dosage , Antifungal Agents/pharmacology , Candida albicans/drug effects , Candidiasis/drug therapy , Disease Models, Animal , Drug Evaluation, Preclinical , Echinocandins , Mannich Bases/administration & dosage , Mannich Bases/pharmacology , Mice , Microbial Sensitivity Tests , Models, Animal , Molecular Structure , Peptides, Cyclic/administration & dosage , Peptides, Cyclic/pharmacology , SolubilityABSTRACT
Semisynthetic modifications at position-12 (ornithine-5-position, hemiaminal function) of mulundocandin were carried out to improve its chemical stability. New carbon-carbon (C-C) and carbon-hydrogen (C-H) linkage at hemiaminal function -12 has been achieved. Lewis acid catalyzed introduction of electron rich aryl group at position-12 of mulundocandin is developed. Synthesized mulundocandin analogues were evaluated for their chemical stability and antifungal activity against C. albicans and A. fumigatus.
Subject(s)
Antifungal Agents/pharmacology , Ornithine/pharmacology , Peptides, Cyclic/pharmacology , Amines/chemistry , Animals , Antifungal Agents/administration & dosage , Antifungal Agents/chemistry , Candida albicans/drug effects , Candida albicans/growth & development , Candidiasis/drug therapy , Drug Stability , Echinocandins , Injections, Intraperitoneal , Mice , Ornithine/chemistry , Peptides, Cyclic/administration & dosage , Peptides, Cyclic/chemistryABSTRACT
Mulundocandin (1), is an echinocandin class of lipopeptide. It has wide spectrum of antifungal activity against Candida and Aspergillus species. Semisynthetic modification at Ornithine-5-hydroxyl (hemiaminal function) of 1 was carried out to improve solution stability and hence in vivo activity. Synthesis of ether (C-OR), thioether (C-SR) and C-N linkage at hemiaminal function have been described. All synthetic analogues were evaluated for their stability in aqueous solution and found to be more stable than mulundocandin. Antifungal activity of Orn-5 analogues was evaluated both in vitro against Candida albicans and Aspergillus fumigatus by agar well method and in vivo (oral and intraperitoneal) in C. albicans infected Swiss mice. Results of in vivo assays of analogues 2-9 by the oral route suggests that the introduction of either oxygen nucleophiles (-OR) or sulphur nucleophiles (-SR), at either Orn-5 or at both Orn-5 and HTyr-4 positions, results in retaining the activity of the parent compound with improved aqueous stability in most cases. Compound 9 has shown improved antifungal activity in comparison to mulundocandin by oral application in Swiss mice.
